Picture of BioArctic AB logo

BIOA B BioArctic AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: BioArctic's Leqembi Approved For Treatment Of Alzheimer's In Israel

July 12 (Reuters) - BioArctic AB  BIOAb.ST :
    * LEQEMBI APPROVED FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IN
ISRAEL

Source text for Eikon:  ID:nPnbyMpSVa 
Further company coverage:  BIOAb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on BioArctic AB

See all news